...
首页> 外文期刊>Clinical reviews in bone and mineral metabolism >Osteoporosis in Veterans with Spinal Cord Injury: an Overview of Pathophysiology, Diagnosis, and Treatments
【24h】

Osteoporosis in Veterans with Spinal Cord Injury: an Overview of Pathophysiology, Diagnosis, and Treatments

机译:具有脊髓损伤的退伍军人骨质疏松症:病理生理学,诊断和治疗概述

获取原文
获取原文并翻译 | 示例

摘要

Immediately after spinal cord injury (SCI), approximately 75% of patients suffer rapid and severe loss of bone mineral density (BMD) below the lesion level (i.e., sublesional), leading to osteoporosis (OP) in ~ 60% 1 -year post-injury. The distal femur (DF) and proximal tibia (PT) are most commonly involved, and 70% of SCI patients sustain a low impact fracture at some point in their lifetime, adding disability to an already physically challenged population. Unfortunately, OP treatments for post-menopausal women are not as effective for OP post-SCI. Mechanisms of new agents targeting the neurogenic etiology of bone resorption (i.e., denosumab and anti-sclerostin antibodies) may hold greater potential and are discussed. Furthermore, standardized DXA protocols with normative BMD values for the DF and PT sites have not been established, so diagnosing OP is problematic. This review will summarize the pathophysiology of sublesional OP after SCI, the unique challenges of diagnosing and managing OP in SCI patients and provide recommendations for future studies. Given the Veterans Health Administration (VA) is the largest health care system in the world for persons with SCI, it is well-equipped to add to gaps in the literature.
机译:脊髓损伤(SCI)后,大约75%的患者患者患者低于病变水平(即余地)的骨矿物密度(BMD)遭受快速和严重的损失,导致骨质疏松症(OP)在〜60%1 - 截面中-受伤。最常见的股骨(DF)和近端胫骨(PT),70%的SCI患者在寿命的某些时候持续低抗冲击,向已有身体挑战的人口增加了残疾。遗憾的是,绝经后妇女的妇女治疗对SCI后期不如op。靶向骨吸收神经源性病因的新试剂的机制(即,Denosumab和抗硬化蛋白抗体)可以容纳更大的潜力并被讨论。此外,尚未建立具有规范性BMD值的标准化DXA协议,因此诊断OP是有问题的。本次审查将总结SCI后余额OP的病理生理学,在SCI患者中诊断和管理OP的独特挑战,并为未来的研究提供了建议。鉴于退伍军人健康管理局(VA)是世界上全球最大的医疗保健系统,适用于SCI的人,它很好地为文献中的差距增加到差距。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号